Synthesis and in Silico Studies of a Benzenesulfonyl Curcumin Analogue as a New Anti Dengue Virus Type 2 (DEN2) NS2B/NS3

Ihsan Ikhtiarudin


Curcumin has been reported can interact with multiple molecular targets involved in a large variety of diseases. Accumulated evidence indicated curcumin plays an inhibitory role against infection of numerous viruses. Some studies have been reported that curcumin can interfere the infection processes of dengue virus. In this work, a benzenesulfonyl curcumin, (3E,5E)-3,5-bis(4-methoxybenzylidene)-1-(phenylsulfonyl)piperidin-4-one (compound 2) has been synthesized by two steps of reactions. The structure of compound 2 has been established based on the interpretation of spectral data include UV, FT-IR, MS/MS, 1H and 13C NMR. Then, the in silico studies have been also performed to predict the potency of compound 2 as inhibitor for dengue virus Type 2 (DEN 2) NS2B/NS3 protease. The in silico studies showed that compound 2 has hydrogen bonding with His51 residue, and amazingly that the other catalytic triad such as Asp75 and Ser135 were also showed interactions with the ligand. It is presumably that this compound showed very good activity against DEN2 and can be developed as a new inhibitor for dengue viruses.



Curcumin, Dengue virus, Molecular docking, Molecular dynamic.

Full Text:



Chambers TJ, Nestorowicz A, Amberg SM, Rice CM. 1993. Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J Virol. 67(11): 6797-807.

Eryanti Y, Herlina T, Zamri A, Halim SNAH, Shiono Y, Syah YM, Supratman U. 2014. 3.5-Bis(2-hydroxybenzylidene) piperidin-4-one. Molbank. 2014(2): M825. doi: 10.3390/M825.

Falgout B, Pethel M, Zhang Y, Lai C. 1991. Both non structural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus non structural protein. J Virol. 65(5): 2467–75.

Frimayanti N, Chee CF, Zain SM, Rahman NA. 2011. Design of new competitive dengue NS2B/NS3 protease inhibitors – a computational approach. Int J Mol Sci. 12(12): 1089-100. doi: 10.3390/ijms12021089.

Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ. 2010. Dengue: a continuing global threat. Nat Rev Microbiol., 8(12 Suppl): S7-16. doi: 10.1038/nrmicro2460.

Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. Journal of Molecular Graphics. 14(1): 33-8. doi: 10.1016/0263-7855(96)00018-5.

Jasril J, Ikhtiarudin I, Zamri A, Teruna HY, Frimayanti N. 2017. New fluorinated chalcone and pyrazoline analogs: synthesis, docking and molecular dynamic studies as anti cancer agents. Thai Journal of Pharmaceutical Sciences. 41(3): 1-6.

Kumar B, Singh V, Shankar R, Kumar K, Rawal RK. 2017. Synthetic and medicinal properties of structurally modified curcumin. Curr Top Med Chem. 17(2): 148-161. doi: 10.2174/1568026616666160605050052

Mathew D, Hsu W-L. 2018. Antiviral potential of curcumin. Journal of functional foods. 40): 692-9. doi: 10.1016/j.jff.2017.12.017.

Morens D, Fauci A. 2008. Dengue and hemorrhagic fever: a potential threat to public health in United States. J Am Med Assoc. 299(2): 214-6. doi: 10.1001/jama.2007.31-a.

Nelson MT, Humphrey W, Gursoy A, Dalke, A, Kalé LV, Skeel RD, Schulten, K. 1996. NAMD: a parallel, object-oriented molecular dynamics program. The International Journal of High Performance Computing Application. 10(4): 251-68. doi: 10.1177/109434209601000401

Padilla-S L, Rodriguez A, Gonzales MM, Gallego-G JC, Castaño-O JC. 2014. Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro. Arch Virol. 159(3): 573-9. doi: 10.1007/s00705-013-1849-6.

Powers CN, Setzer WN. 2016. An in-silico investigation of phytochemicals as antiviral agents dengue fever. Com Chem High Throughput screen. 19(7): 516-36. doi: 10.2174/1386207319666160506123715.

Sampath A, Padmanabhan R. 2009. Molecular targets for flavivirus drug discovery. Antivir Res. 81(1): 6–15. doi: 10.1016/j.antiviral.2008.08.004.



  • There are currently no refbacks.

Copyright (c) 2019 Indonesian Journal of Pharmacy

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats